Pod1um-304: Phase Iii Study of Retifanlimab Plus Platinum-Based Chemotherapy (Chemo) as First-Line (1l) Therapy for Nonsquamous or Squamous Metastatic Nonesmall Cell Lung Cancer (Mnsclc)

Lu, S.Vynnychenko, O.Kulyaba, Y.Kuchava, V.Ibrahim, A.Moiseenko, F. V.Bondarenko, I.2025-04-252025-04-2520240923-75341569-8041https://doi.org/10.1016/j.annonc.2024.10.660https://hdl.handle.net/20.500.14365/6055Bondarenko, Igor/0000-0002-7071-2471eninfo:eu-repo/semantics/closedAccessPod1um-304: Phase Iii Study of Retifanlimab Plus Platinum-Based Chemotherapy (Chemo) as First-Line (1l) Therapy for Nonsquamous or Squamous Metastatic Nonesmall Cell Lung Cancer (Mnsclc)Conference Object10.1016/j.annonc.2024.10.660